238 related articles for article (PubMed ID: 37342006)
1. Atlas of gut microbe-derived products from aromatic amino acids and risk of cardiovascular morbidity and mortality.
Nemet I; Li XS; Haghikia A; Li L; Wilcox J; Romano KA; Buffa JA; Witkowski M; Demuth I; König M; Steinhagen-Thiessen E; Bäckhed F; Fischbach MA; Tang WHW; Landmesser U; Hazen SL
Eur Heart J; 2023 Aug; 44(32):3085-3096. PubMed ID: 37342006
[TBL] [Abstract][Full Text] [Related]
2. Dysregulated meta-organismal metabolism of aromatic amino acids in alcohol-associated liver disease.
Mrdjen M; Huang E; Pathak V; Bellar A; Welch N; Dasarathy J; Streem D; McClain CJ; Mitchell M; Radaeva S; Barton B; Szabo G; Dasarathy S; Wang Z; Hazen SL; Brown JM; Nagy LE
Hepatol Commun; 2023 Nov; 7(11):. PubMed ID: 37820283
[TBL] [Abstract][Full Text] [Related]
3. Microbe-derived uremic solutes enhance thrombosis potential in the host.
Nemet I; Funabashi M; Li XS; Dwidar M; Sangwan N; Skye SM; Romano KA; Cajka T; Needham BD; Mazmanian SK; Hajjar AM; Rey FE; Fiehn O; Tang WHW; Fischbach MA; Hazen SL
mBio; 2023 Nov; 14(6):e0133123. PubMed ID: 37947418
[No Abstract] [Full Text] [Related]
4. Plasma microbiome-modulated indole- and phenyl-derived metabolites associate with advanced atherosclerosis and postoperative outcomes.
Cason CA; Dolan KT; Sharma G; Tao M; Kulkarni R; Helenowski IB; Doane BM; Avram MJ; McDermott MM; Chang EB; Ozaki CK; Ho KJ
J Vasc Surg; 2018 Nov; 68(5):1552-1562.e7. PubMed ID: 29248242
[TBL] [Abstract][Full Text] [Related]
5. Indolic Structure Metabolites as Potential Biomarkers of Non-infectious Diseases.
Beloborodova NV; Chernevskaya EA; Getsina ML
Curr Pharm Des; 2021; 27(2):238-249. PubMed ID: 33092503
[TBL] [Abstract][Full Text] [Related]
6. Identification of Gut Microbiome Signatures Associated with Indole Pathway in Tryptophan Metabolism in Patients Undergoing Hemodialysis.
Huang JK; Wu PH; Chen ZF; Liu PY; Kuo CC; Chuang YS; Lu MZ; Kuo MC; Chiu YW; Lin YT
Biomolecules; 2024 May; 14(6):. PubMed ID: 38927027
[TBL] [Abstract][Full Text] [Related]
7. The Accumulation of Gut Microbiome-derived Indoxyl Sulfate and P-Cresyl Sulfate in Patients With End-stage Renal Disease.
Lin X; Liang W; Li L; Xiong Q; He S; Zhao J; Guo X; Xiang S; Zhang P; Wang H; Ying C; Yao Y; Zuo X
J Ren Nutr; 2022 Sep; 32(5):578-586. PubMed ID: 34736844
[TBL] [Abstract][Full Text] [Related]
8. Targeted metabolomics analysis of aromatic amino acids and their gut microbiota-host cometabolites in rat serum and urine by liquid chromatography coupled with tandem mass spectrometry.
Zeng Y; Luo L; Hou W; Lu B; Gong J; Chen J; Zhang X; Han B; Xie Z; Liao Q
J Sep Sci; 2017 Aug; 40(16):3221-3230. PubMed ID: 28605162
[TBL] [Abstract][Full Text] [Related]
9. Indoles - Gut Bacteria Metabolites of Tryptophan with Pharmacotherapeutic Potential.
Konopelski P; Ufnal M
Curr Drug Metab; 2018; 19(10):883-890. PubMed ID: 29708069
[TBL] [Abstract][Full Text] [Related]
10. Bisphenol-A alters microbiota metabolites derived from aromatic amino acids and worsens disease activity during colitis.
DeLuca JA; Allred KF; Menon R; Riordan R; Weeks BR; Jayaraman A; Allred CD
Exp Biol Med (Maywood); 2018 Jun; 243(10):864-875. PubMed ID: 29874946
[TBL] [Abstract][Full Text] [Related]
11. Inulin-type fructan intervention restricts the increase in gut microbiome-generated indole in patients with peritoneal dialysis: a randomized crossover study.
Li L; Xiong Q; Zhao J; Lin X; He S; Wu N; Yao Y; Liang W; Zuo X; Ying C
Am J Clin Nutr; 2020 May; 111(5):1087-1099. PubMed ID: 31942927
[TBL] [Abstract][Full Text] [Related]
12. Activation of aryl hydrocarbon receptor (AhR) in Alzheimer's disease: role of tryptophan metabolites generated by gut host-microbiota.
Salminen A
J Mol Med (Berl); 2023 Mar; 101(3):201-222. PubMed ID: 36757399
[TBL] [Abstract][Full Text] [Related]
13. A gut bacterial pathway metabolizes aromatic amino acids into nine circulating metabolites.
Dodd D; Spitzer MH; Van Treuren W; Merrill BD; Hryckowian AJ; Higginbottom SK; Le A; Cowan TM; Nolan GP; Fischbach MA; Sonnenburg JL
Nature; 2017 Nov; 551(7682):648-652. PubMed ID: 29168502
[TBL] [Abstract][Full Text] [Related]
14. Thrombolome and Its Emerging Role in Chronic Kidney Diseases.
Fryc J; Naumnik B
Toxins (Basel); 2021 Mar; 13(3):. PubMed ID: 33803899
[TBL] [Abstract][Full Text] [Related]
15. Gut Microbiota and Cardiovascular Disease.
Witkowski M; Weeks TL; Hazen SL
Circ Res; 2020 Jul; 127(4):553-570. PubMed ID: 32762536
[TBL] [Abstract][Full Text] [Related]
16. Disorder of gut amino acids metabolism during CKD progression is related with gut microbiota dysbiosis and metagenome change.
Liu Y; Li J; Yu J; Wang Y; Lu J; Shang EX; Zhu Z; Guo J; Duan J
J Pharm Biomed Anal; 2018 Feb; 149():425-435. PubMed ID: 29169110
[TBL] [Abstract][Full Text] [Related]
17. Intestinal Microbial Metabolites Are Linked to Severity of Myocardial Infarction in Rats.
Lam V; Su J; Hsu A; Gross GJ; Salzman NH; Baker JE
PLoS One; 2016; 11(8):e0160840. PubMed ID: 27505423
[TBL] [Abstract][Full Text] [Related]
18. Evaluating effects of penicillin treatment on the metabolome of rats.
Sun J; Schnackenberg LK; Khare S; Yang X; Greenhaw J; Salminen W; Mendrick DL; Beger RD
J Chromatogr B Analyt Technol Biomed Life Sci; 2013 Aug; 932():134-43. PubMed ID: 23831706
[TBL] [Abstract][Full Text] [Related]
19. METABOLIC DYSBIOSIS OF THE GUT MICROBIOTA AND ITS BIOMARKERS.
Sitkin SI; Tkachenko EI; Vakhitov TY
Eksp Klin Gastroenterol; 2016 Jul; 12(12):6-29. PubMed ID: 29889418
[TBL] [Abstract][Full Text] [Related]
20. Gut microbiota generation of protein-bound uremic toxins and related metabolites is not altered at different stages of chronic kidney disease.
Gryp T; De Paepe K; Vanholder R; Kerckhof FM; Van Biesen W; Van de Wiele T; Verbeke F; Speeckaert M; Joossens M; Couttenye MM; Vaneechoutte M; Glorieux G
Kidney Int; 2020 Jun; 97(6):1230-1242. PubMed ID: 32317112
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
